Expression of Concern: Randomized comparison of superovulation with letrozole vs. clomiphene citrate in an IUI program for women with recently surgically treated minimal to mild endometriosis

Hatem Abu Hashim, Mohamed El Rakhawy, Ibrahim Abd Elaal
Acta obstetricia et gynecologica Scandinavica · 2011 · vol. 91(3) , pp. 338–345 · doi:10.1111/j.1600-0412.2011.01346.x · PMID:22181973 · W1539075644
article OA: bronze CC0 ⤵ 21 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This RCT found letrozole superovulation did not improve pregnancy rates compared to clomiphene citrate in women with mild endometriosis undergoing IUI.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate pregnancy rates with letrozole and clomiphene citrate (CC) alone for superovulation in an intrauterine insemination program for women with recently surgically treated minimal to mild endometriosis. DESIGN: A randomized controlled trial following the CONSORT criteria. SETTING: University teaching hospital and a private practice setting. PATIENTS: 136 women with primary infertility due to minimal to mild endometriosis who did not achieve pregnancy after six to 12 months following laparoscopic treatment. INTERVENTIONS: Superovulation using 5 mg letrozole/day (69 women, 220 cycles) or 100 mg CC/day (67 women, 213 cycles) for five days combined with intrauterine insemination up to four cycles. MAIN OUTCOME MEASURES: Clinical pregnancy rate per cycle, cumulative pregnancy rate after four cycles, number of follicles, serum estradiol, endometrial thickness on the day of human chorionic gonadotropin administration, serum progesterone, miscarriage and live birth rates. RESULTS: The clinical pregnancy rate per cycle and the cumulative pregnancy rate after four cycles were comparable (15.9 vs. 14.5% and 64.7 vs. 57.2%; p=0.82, p=0.71 in letrozole and CC groups, respectively). Two twin pregnancies occurred in the CC/intrauterine insemination group. Miscarriage and live birth rates were comparable (11.4 vs. 12.9% and 44.9 vs. 40.3%; p=0.47, p=0.62 in letrozole and CC groups, respectively). The total number of follicles and serum estradiol on the day of human chorionic gonadotropin administration were significantly increased in the CC group. CONCLUSIONS: Superovulation with letrozole is not more effective than clomiphene citrate alone in an intrauterine insemination program for women with minimal to mild endometriosis who did not achieve pregnancy after six to 12 months following laparoscopic treatment. ClinicalTrials.gov ID: NCT01334762.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Aromatase Inhibitors Clomiphene Endometriosis Fertility Agents, Female Infertility, Female Nitriles Superovulation Triazoles Adult Aromatase Inhibitors Clomiphene Drug Administration Schedule Endometriosis Endometriosis Female Fertility Agents, Female Humans Infertility, Female Infertility, Female Insemination, Artificial

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (29)

Cited by (21)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:23.388809+00:00
License: CC0 · commercial use OK